LIAISON PSA - India CDSCO Medical Device Registration

LIAISON PSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000113_1fde04a38f8f29c96e9fb07e25fe1f24_4b4e68072f0d4a4935292b4a8b9f1857. This device is marketed under the brand name LIAISON fPSA. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

LIAISON PSA

UID: IMP/IVD/2019/000113_1fde04a38f8f29c96e9fb07e25fe1f24_4b4e68072f0d4a4935292b4a8b9f1857

Brand Name

LIAISON fPSA

License Holder

Diasorin Healthcare India Pvt. Ltd.

Device Class

Class C

Approving Authority

CDSCO

Product Information

In vitro assay for the quantitative determination of human prostate-specific antigen (LIAISON fPSA) in human serum and plasma (LIAISON fPSA) during the follow-up of patients with carcinoma of the prostate. The test has to be performed on the LIAISON® Analyzer family.